FR21C1002I1 - VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS - Google Patents
VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARISInfo
- Publication number
- FR21C1002I1 FR21C1002I1 FR21C1002C FR21C1002C FR21C1002I1 FR 21C1002 I1 FR21C1002 I1 FR 21C1002I1 FR 21C1002 C FR21C1002 C FR 21C1002C FR 21C1002 C FR21C1002 C FR 21C1002C FR 21C1002 I1 FR21C1002 I1 FR 21C1002I1
- Authority
- FR
- France
- Prior art keywords
- vaccine
- protection against
- lawsonia intracellularis
- against lawsonia
- intracellularis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4616108P | 2008-04-18 | 2008-04-18 | |
EP08154764 | 2008-04-18 | ||
US11175608P | 2008-11-06 | 2008-11-06 | |
EP08105738 | 2008-11-06 | ||
PCT/EP2009/054516 WO2009144088A2 (en) | 2008-04-18 | 2009-04-16 | Vaccine for protection against lawsonia intracellulars |
EP09753743.5A EP2268308B1 (en) | 2008-04-18 | 2009-04-16 | Vaccine for protection against lawsonia intracellulars |
Publications (1)
Publication Number | Publication Date |
---|---|
FR21C1002I1 true FR21C1002I1 (en) | 2021-03-05 |
Family
ID=41212183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR21C1002C Active FR21C1002I1 (en) | 2008-04-18 | 2021-01-18 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS |
Country Status (13)
Country | Link |
---|---|
US (3) | US20110033496A1 (en) |
EP (3) | EP2268308B1 (en) |
JP (2) | JP6026106B2 (en) |
CN (1) | CN102006883A (en) |
BR (2) | BRPI0909769A2 (en) |
CA (1) | CA2717969C (en) |
DK (2) | DK3351267T3 (en) |
ES (1) | ES2666671T3 (en) |
FR (1) | FR21C1002I1 (en) |
HU (2) | HUE038294T2 (en) |
PL (2) | PL3351267T3 (en) |
TW (1) | TWI551295B (en) |
WO (1) | WO2009144088A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI551295B (en) * | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | Vaccine for protection against lawsonia intracellularis |
WO2011054951A1 (en) | 2009-11-09 | 2011-05-12 | Intervet International B.V. | Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells |
KR101837768B1 (en) | 2011-05-25 | 2018-03-12 | 건국대학교 산학협력단 | Protein for dianosing porcine proliferative enteritis and application thereof |
EP3076995B1 (en) | 2013-12-03 | 2020-03-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
CA2931137C (en) | 2013-12-03 | 2023-03-14 | Intervet International B.V. | Vaccine against porcine circo virus type 2 |
ES2695172T3 (en) * | 2013-12-03 | 2019-01-02 | Intervet Int Bv | Swine vaccine against SRRP and Lawsonia intracellularis |
WO2016124623A1 (en) | 2015-02-04 | 2016-08-11 | Intervet International B.V. | A vaccine for use against subclinical lawsonia infection in a pig |
US10751405B2 (en) * | 2015-02-04 | 2020-08-25 | Intervet Inc. | Vaccine for use against subclinical Lawsonia infection in a pig |
CN108135990A (en) * | 2015-10-22 | 2018-06-08 | 英特维特国际股份有限公司 | For MDA animals showing positives to be protected to resist the vaccine of the lesion as caused by Lawsonia intracellularis infection |
JP6655414B2 (en) | 2016-02-15 | 2020-02-26 | 株式会社デンソー | Exhaust gas purification system |
CA3084042A1 (en) | 2017-12-04 | 2019-06-13 | Intervet International B.V. | Vaccination with replicon particles and oil adjuvant |
WO2019121513A1 (en) | 2017-12-18 | 2019-06-27 | Intervet International B.V. | Swine influenza a virus vaccine |
CN111757752A (en) * | 2018-02-28 | 2020-10-09 | 勃林格殷格翰动物保健有限公司 | Method for reducing skatole and/or indole in animals |
JP2023530133A (en) | 2020-06-19 | 2023-07-13 | インターベット インターナショナル ベー. フェー. | Swine Influenza A Virus Vaccine Containing a Nucleic Acid Construct Having a Specific Order of Genes |
BR112022025735A2 (en) | 2020-06-19 | 2023-01-03 | Intervet Int Bv | SWINE INFLUENZA VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT COMPRISING FIRST, SECOND, AND THIRD NUCLEIC ACID SEQUENCES ENCODING DISTINCTIVE NEURAMINIDASE ANTIGENS OF THE VIRUS |
CN115697398A (en) | 2020-06-19 | 2023-02-03 | 英特维特国际股份有限公司 | Swine influenza A virus vaccine comprising two different RNA replicon particles |
CN115836082A (en) | 2020-06-19 | 2023-03-21 | 英特维特国际股份有限公司 | Swine influenza A virus vaccines comprising nucleic acid constructs encoding antigens of a particular viral lineage |
CN118139640A (en) | 2021-10-25 | 2024-06-04 | 英特维特国际股份有限公司 | Vaccine for protecting piglets against infection with swine influenza A virus |
AU2022375120A1 (en) | 2021-11-01 | 2024-04-11 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic gel compositions |
WO2024068637A1 (en) | 2022-09-27 | 2024-04-04 | Intervet International B.V. | A method of culturing lawsonia intracellularis bacteria |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0382271T3 (en) | 1989-02-04 | 1995-05-01 | Akzo Nobel Nv | Tocoler as adjuvants in vaccines |
FR2649012B1 (en) | 1989-07-03 | 1991-10-25 | Seppic Sa | INJECTABLE MULTIPHASIC EMULSIONS |
US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
ATE329031T1 (en) * | 1995-11-30 | 2006-06-15 | Agriculture Victoria Serv Pty | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF LAWSONIA INTRACELLULARIS INFECTIONS |
EP1177213A4 (en) * | 1999-05-13 | 2002-08-28 | Pfizer Prod Inc | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
EP1094070A3 (en) | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis proteins, and related methods and materials |
JP2004529854A (en) | 2000-09-29 | 2004-09-30 | アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ | Improved vaccines for proliferative ileitis and methods of making and using the same |
DK1586646T3 (en) | 2000-12-20 | 2011-06-27 | Intervet Int Bv | Lawsonia intracellularis vaccine |
UA87665C2 (en) | 2003-07-25 | 2009-08-10 | Берингер Ингельхайм Ветмедика, Инк. | Avirulent isolate of lawsonia intracellularis of european origin, vaccine for immunization of animals, use of avirulent isolate as vaccine, method for producing vaccine, method for culture of lawsonia intracellularis, method for diagnosing proliferative enteropathy in pigs, method for producing antiseurum to lawsonia intracellularis |
CA2554472A1 (en) | 2004-01-22 | 2005-08-04 | Intervet International B.V. | Lawsonia intracellularis subunit vaccines |
KR20070008625A (en) * | 2004-04-05 | 2007-01-17 | 화이자 프로덕츠 인코포레이티드 | Microfluidized oil-in-water emulsions and vaccine compositions |
CN102657855B (en) * | 2004-09-22 | 2015-12-09 | 葛兰素史密丝克莱恩生物有限公司 | For carrying out the immunogenic composition of staphylococcus inoculation |
US20070212373A1 (en) | 2004-12-08 | 2007-09-13 | Akzo Nobel N.V. | Lawsonia Intracellularis 26 Kd Subunit Vaccine |
US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
ES2425228T3 (en) | 2005-09-09 | 2013-10-14 | Intervet International B.V. | Vaccine against PCV-2 |
MX2008011247A (en) | 2006-03-03 | 2008-09-11 | Merial Ltd | Mycoplasma hyopneumoniae vaccine. |
NZ570805A (en) * | 2006-03-30 | 2011-10-28 | Glaxosmithkline Biolog Sa | Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus |
KR101358517B1 (en) | 2006-04-10 | 2014-02-06 | 인터벳 인터내셔널 비.브이. | Vaccine against mycoplasma prrsv |
US8470336B2 (en) * | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
MX2008015164A (en) | 2006-05-30 | 2008-12-12 | Intervet Int Bv | Vaccine against rickettsia-like organisms. |
TWI551295B (en) * | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | Vaccine for protection against lawsonia intracellularis |
TWI449533B (en) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
US10751405B2 (en) | 2015-02-04 | 2020-08-25 | Intervet Inc. | Vaccine for use against subclinical Lawsonia infection in a pig |
-
2009
- 2009-03-30 TW TW098110510A patent/TWI551295B/en active
- 2009-04-16 DK DK18154850.4T patent/DK3351267T3/en active
- 2009-04-16 DK DK09753743.5T patent/DK2268308T3/en active
- 2009-04-16 HU HUE09753743A patent/HUE038294T2/en unknown
- 2009-04-16 US US12/988,083 patent/US20110033496A1/en not_active Abandoned
- 2009-04-16 BR BRPI0909769-4A patent/BRPI0909769A2/en not_active Application Discontinuation
- 2009-04-16 CN CN2009801136792A patent/CN102006883A/en active Pending
- 2009-04-16 EP EP09753743.5A patent/EP2268308B1/en active Active
- 2009-04-16 WO PCT/EP2009/054516 patent/WO2009144088A2/en active Application Filing
- 2009-04-16 EP EP20167953.7A patent/EP3708186A1/en active Pending
- 2009-04-16 EP EP18154850.4A patent/EP3351267B1/en active Active
- 2009-04-16 PL PL18154850T patent/PL3351267T3/en unknown
- 2009-04-16 BR BR122019000869-8A patent/BR122019000869B1/en active IP Right Grant
- 2009-04-16 JP JP2011504462A patent/JP6026106B2/en active Active
- 2009-04-16 PL PL09753743T patent/PL2268308T3/en unknown
- 2009-04-16 CA CA2717969A patent/CA2717969C/en active Active
- 2009-04-16 ES ES09753743.5T patent/ES2666671T3/en active Active
-
2012
- 2012-10-22 US US13/657,210 patent/US8597662B2/en active Active
-
2013
- 2013-07-17 US US13/944,234 patent/US9198963B2/en active Active
-
2015
- 2015-08-11 JP JP2015158693A patent/JP6138875B2/en active Active
-
2020
- 2020-11-25 HU HUS2000047C patent/HUS2000047I1/en unknown
-
2021
- 2021-01-18 FR FR21C1002C patent/FR21C1002I1/en active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0909769A2 (en) | 2015-08-11 |
CA2717969A1 (en) | 2009-12-03 |
EP3351267A1 (en) | 2018-07-25 |
DK2268308T3 (en) | 2018-05-22 |
WO2009144088A2 (en) | 2009-12-03 |
US9198963B2 (en) | 2015-12-01 |
HUE038294T2 (en) | 2018-10-29 |
CA2717969C (en) | 2016-06-07 |
EP3351267B1 (en) | 2020-08-05 |
JP2016026154A (en) | 2016-02-12 |
PL3351267T3 (en) | 2020-11-30 |
CN102006883A (en) | 2011-04-06 |
HUS2000047I1 (en) | 2020-12-28 |
JP6026106B2 (en) | 2016-11-16 |
US20110033496A1 (en) | 2011-02-10 |
TW201002342A (en) | 2010-01-16 |
BR122019000869B1 (en) | 2023-11-07 |
PL2268308T3 (en) | 2018-07-31 |
EP2268308A2 (en) | 2011-01-05 |
EP3708186A1 (en) | 2020-09-16 |
ES2666671T3 (en) | 2018-05-07 |
TWI551295B (en) | 2016-10-01 |
JP6138875B2 (en) | 2017-05-31 |
EP2268308B1 (en) | 2018-03-14 |
US8597662B2 (en) | 2013-12-03 |
DK3351267T3 (en) | 2020-09-21 |
WO2009144088A3 (en) | 2010-05-06 |
US20130302372A1 (en) | 2013-11-14 |
US20130045228A1 (en) | 2013-02-21 |
JP2011516600A (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR21C1002I1 (en) | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS | |
BRPI0910283A2 (en) | bagging set | |
ZA201101481B (en) | Vaccine | |
DK2114993T3 (en) | VACCINE | |
IL211184A0 (en) | Polyvalent vaccine | |
HRP20151124T1 (en) | Vaccine | |
BRPI1005919A2 (en) | immunogenic composition | |
DK2341834T3 (en) | Improved X-ray protection | |
GB0700135D0 (en) | Vaccine | |
GB0810869D0 (en) | Vaccine adjuvant composition | |
GB0810710D0 (en) | Vaccine | |
ZA201007402B (en) | Vaccine | |
GB0816284D0 (en) | Vaccine | |
GB0805356D0 (en) | Vaccine adjuvant composition | |
EP2252326A4 (en) | Vaccine compositions | |
GB0816447D0 (en) | Vaccine | |
GB0801122D0 (en) | Vaccine composition | |
HUE051465T2 (en) | Vaccine for protection against lawsonia intracellularis | |
GB0820404D0 (en) | Vaccine compositions | |
GB0802326D0 (en) | Vaccine Composition | |
UA16875S (en) | PACKAGING FOR CHOCOLATE | |
GB0702363D0 (en) | Vaccine composition | |
UA16478S (en) | PACKAGING FOR PHYTOCHAI | |
TH101459B (en) | Packaging for packaging | |
UA18024S (en) | PACKAGING FOR PHYTOCHAI |